FROM THE EDITOR

How Low Can and Should You Go?

By Iqbal K. Ahmed, MD, FRCSC

When is Glaucoma “Controlled”?

MIGS is changing the conventional wisdom in a way that’s beneficial for patients

By Inder Paul Singh, MD

Diagnosing & Managing Glaucoma: A Case Study

The importance of imaging the macula in glaucoma and its effects on patient education

By Thomas W. Samuelson, M.D.

Outliers & Moving Targets

Glaucoma management at the extremes of IOP

By Tony Realini, MD, MPH

IOP At-home Monitoring

Assessing diurnal IOP fluctuations and modern day assessment with home rebound tonometry

By Iqbal K. Ahmed, MD, FRCSC, Ayda M. Shahidi, OD, PhD, Harrish Nithianandan, HBSc

Experts Discuss Tracking Glaucoma

Improving your view of the angle

Making History with ABiC

A story of two ophthalmologists — one doctor, one patient

A Simple Treatment Regimen at Last

Glaucoma specialists drive development of quality, sterile compounded medications to address compliance, cost, and tolerability

By Mark L. Baum

Innovative New Microstent for MIGS

The Hydrus Microstent bypasses the trabecular meshwork and dilates and augments the nasal quadrant of Schlemm’s canal

By Thomas W. Samuelson, M.D.

Addressing Drop Therapy’s Biggest Weakness

My experience with a new, simpler dosing option

By Inder Paul Singh, MD

Unbundle Modifiers

When used correctly, X modifiers support claims

By Kevin J. Corcoran, COE, CPC, CPMA, FNAO